VIVO BIO 

Vivo Bio Tech Limited has secured CPCSEA approval, funding, and completed a 15,000 sq. ft. large animal facility. 

The facility supports housing, breeding, and studies on canines, pigs, mini-pigs, sheep, and goats. Operations include PK, PD, surgical, and toxicology studies, serving major pharma and biopharma clients.

Vivo Bio Tech’s new large animal facility enhances its ecosystem, which includes In-vitro, In-vivo, Eco-Toxicology, and Analytical services. 

It enables delivery of comprehensive IND packages, placing Vivo among elite CROs supporting both large and small animal research. 

The company aims to become a key discovery partner for major pharma firms, with future updates to follow.